Dr.  

Philip Hampton


Presentations

12-week secukinumab treatment is consistently efficacious in moderate-to-severe psoriasis patients regardless of prior treatment with systemics, including conventional systemics, based on post-hoc analysis 09 October 2019 00:00 - 00:00

Abstracts

12-week secukinumab treatment is consistently efficacious in moderate-to-severe psoriasis patients regardless of prior treatment with systemics, including conventional systemics, based on post-hoc analysis Psoriasis More